Supplemental Iron: A Key to Optimizing the Response of Cancer‐Related Anemia to rHuEPO?-Reference-Cited by-同舟云学术

Supplemental Iron: A Key to Optimizing the Response of Cancer‐Related Anemia to rHuEPO?

Published:1998-08 Issue:4 Volume:3 Page:275-278
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:The Oncologist

Author:

Henry David H.¹

Affiliation:

1. Allegheny University of the Health Sciences, Graduate Hospital, Philadelphia, Pennsylvania, USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.3-4-275

Reference38 articles.

1. the NKF‐DOQI Anemia Work Group. NKF‐DOQI™ Clinical Practice Guidelines for the treatment of anemia of chronic renal failure;Eschbach JW;Am J Kidney Dis,1997

2. The anemia of chronic disorders;Cartwright GE;Semin Hematol,1966

3. Cancer‐related anemia: its causes and characteristics;Spivak JL;Semin Oncol,1994

4. Implications of the Anemia of Chronic Disorders in Patients Anticipating Radiotherapy

5. Modulation of the Production of Erythropoietin by Cytokines: In vitro Studies and Their Clinical Implications1

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines;Tumori Journal;2020-06-02

2. Predictive factors in patients eligible for pegfilgrastim prophylaxis focusing on RDI using ordered logistic regression analysis;Medical Oncology;2018-03-16

3. Comparative Effects of Aerobic Training and Erythropoietin on Oxygen Uptake in Untrained Humans;Journal of Strength and Conditioning Research;2016-08

4. Current management of anemia in oncology;Transfusion-Free Medicine and Surgery;2014-08-01

5. Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial;Supportive Care in Cancer;2013-05-19